Heather E Easton, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 522 N Hancock St, Ottumwa, IA 52501 Phone: 641-683-0800 Fax: 641-683-0801 |
Raegan Renee Johns, ARNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 201 S Market St, Ottumwa, IA 52501 Phone: 641-683-5773 Fax: 641-226-5759 |
Brooke E. Nichols, NP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1255 Theatre Dr, Ottumwa, IA 52501 Phone: 641-451-0382 |
Kyle P Compaan, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1255 Theatre Dr, B, Ottumwa, IA 52501 Phone: 641-684-2551 |
Jasmine Benson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1005 Pennsylvania Ave Ste 207, Ottumwa, IA 52501 Phone: 641-682-5349 Fax: 515-246-4474 |
Samantha Jo Chambers, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1013 Pennsylvania Ave, Ottumwa, IA 52501 Phone: 641-684-3200 |
News Archive
A teaspoon of dirt contains an estimated 10,000 species of bacteria, but it's only one percent of these microbial bugs - the ones that can be grown easily in a lab - that have brought us antibiotics, anticancer agents and other useful drugs.
Impax Pharmaceuticals, a division of Impax Laboratories, Inc., today announced that the U.S. Food and Drug Administration approved RYTARY, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication and / or manganese intoxication.
Contrary to accepted knowledge, blood can bring more oxygen to mice brains when they exercise because the increased respiration packs more oxygen into the hemoglobin, according to an international team of researchers who believe that this holds true for all mammals.
Amira Pharmaceuticals, Inc. announced today the submission of an Investigational New Drug application (IND) of AM461, its internally-discovered, oral drug candidate for the treatment and control of inflammatory and allergic disease linked to the arachidonic acid pathway, to the U.S. Food and Drug Administration.
Heart attack patients won't go to the emergency room as part of a new University of Kentucky plan designed to reduce those patients' risk of dying by nearly 8 percent for every half hour shaved off the time between the ambulance and treatment at the hospital.
› Verified 3 days ago